BIO & Beyond 01: Robert Wenslow - Crystal Pharmatech

In BIO & Beyond Episode 1, we speak with Robert Wenslow, Co-Founder and CBO at Crystal Pharmatech. Drawing on 15 years at MSD and over a decade building a global CDMO, he shares why China’s shift from follower to innovator was bound to happen – and why scientific rigor matters more than sheer scale. 𝗞𝗲𝘆 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗼𝘂𝗿 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻:   • 𝗕𝗲𝘆𝗼𝗻𝗱 𝙈𝙚-𝙏𝙤𝙤: Why China’s biotech wave is now driven by novel molecules and global-caliber talent delivering true breakthrough science.   • 𝗧𝗵𝗲 𝙈𝙤𝙡2𝙈𝙚𝙙 𝗣𝗵𝗶𝗹𝗼𝘀𝗼𝗽𝗵𝘆: How understanding a molecule as a material early on drives a first-time-right approach – from small molecules to LNPs and peptides.   • 𝗖𝘂𝗹𝘁𝘂𝗿𝗲 𝗢𝘃𝗲𝗿 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝘁: Why a dedicated, problem-solving mindset early in R&D creates far greater patient value than chasing late-stage manufacturing volume.